CompanyMRNANasdaqCambridge, MA

Moderna, Inc.

Moderna develops mRNA vaccines and therapeutics for infectious diseases, cancer, and rare diseases.

SEC EDGAR ClinicalTrials.gov modernatx.com

8-KSep 30Latest SEC filing

Sep 30Latest story

September 2026

Moderna creates COO role, brings back Juan Andres as Jerh Collins retires

Sep 30PeopleModerna, Inc.

Moderna completes $3 billion convertible notes offering, upsized from original plan

Sep 1FinancingModerna, Inc.

July 2026

Moderna's norovirus vaccine misses early efficacy bar; flu shot nears FDA decision

Jul 31Quarterly updateModerna, Inc.

Moderna adds former Biogen CFO Michael McDonnell to board

Jul 8PeopleBiogen Moderna, Inc.